BioCardia, Inc.

NasdaqCM:BCDA Stock Report

Market Cap: US$12.0m

BioCardia Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:BCDA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Mar 25BuyUS$2,450Simon StertzerIndividual1,000US$2.45
04 Mar 25BuyUS$35,733Simon StertzerIndividual15,536US$2.30
03 Mar 25BuyUS$1,055Peter AltmanIndividual500US$2.11
03 Mar 25BuyUS$52,332Simon StertzerIndividual22,753US$2.30
07 Feb 25BuyUS$1,488Peter AltmanIndividual600US$2.48
30 Jan 25BuyUS$1,769Peter AltmanIndividual739US$2.40
23 Dec 24BuyUS$2,060Peter AltmanIndividual1,000US$2.06
20 Dec 24SellUS$6,514Edward GillisIndividual3,257US$2.00
05 Dec 24BuyUS$555Peter AltmanIndividual250US$2.22
15 Nov 24BuyUS$2,525Peter AltmanIndividual1,350US$1.87
01 Jul 24BuyUS$1,513Peter AltmanIndividual500US$3.05
21 Jun 24BuyUS$1,645Peter AltmanIndividual500US$3.29
14 Jun 24BuyUS$1,760Peter AltmanIndividual500US$3.52
10 Jun 24BuyUS$3,360Peter AltmanIndividual1,000US$3.36
19 Apr 24BuyUS$1,013Peter AltmanIndividual183.33US$5.52
28 Mar 24BuyUS$195Peter AltmanIndividual33.33US$5.85
26 Mar 24SellUS$124,172Phillip FrostIndividual18,981.68US$8.40

Insider Trading Volume

Insider Buying: BCDA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BCDA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies96,3342.1%
Institutions132,1262.88%
Individual Insiders948,57320.7%
General Public3,407,25274.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 165.4%.

Top Shareholders

Top 25 shareholders own 25.65% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.15%
Andrew Blank
144,536US$378.7k0%no data
3.02%
Simon Stertzer
138,600US$363.1k39.5%no data
3%
Thomas Satterfield
137,497US$360.2k88.4%no data
2.39%
Jim Allen
109,673US$287.3k0%no data
2.37%
Peter Altman
108,420US$284.1k1.73%no data
2.28%
Phillip Frost
104,745US$274.4k0%no data
2.1%
A.G. Family L.P.
96,334US$252.4k239%no data
1.98%
Joseph Daly
90,622US$237.4k0%no data
1.37%
Gerald Peters
62,708US$164.3k0%no data
0.96%
Susquehanna International Group, LLP, Asset Management Arm
43,842US$114.9k-37.9%no data
0.68%
Geode Capital Management, LLC
30,987US$81.2k110%no data
0.65%
David McClung
30,008US$78.6k72.7%no data
0.65%
CM Management, LLC
30,000US$78.6k0%0.07%
0.28%
The Vanguard Group, Inc.
12,884US$33.8k0%no data
0.2%
Edward Gillis
8,968US$23.5k175%no data
0.1%
UBS Asset Management AG
4,750US$12.4k0%no data
0.088%
Morgan Stanley, Investment Banking and Brokerage Investments
4,016US$10.5k13,300%no data
0.079%
Jay Moyes
3,618US$9.5k0%no data
0.073%
Karina Daly
3,333US$8.7k0%no data
0.069%
Richard Krasno
3,146US$8.2k0%no data
0.055%
Rebecca Satterfield
2,500US$6.5k0%no data
0.049%
Peters Family Art Foundation, Endowment arm
2,230US$5.8k0%no data
0.023%
Pingora Partners LLC
1,036US$2.7k0%no data
0.02%
JPMorgan Chase & Co, Brokerage and Securities Investments
899US$2.4k0%no data
0.012%
Tower Research Capital Europe Limited
535US$1.4k-58.3%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/18 23:30
End of Day Share Price 2025/03/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioCardia, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Joseph PantginisH.C. Wainwright & Co.
Emanuela BranchettiH.C. Wainwright & Co.